You are here

Award Data

For best search results, use the search terms first and then apply the filters

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. STTR Phase I: Development of novel ultrasound-visible percutaneous dilation system

    SBC: Perceus, Inc.            Topic: MD

    This broader impact/commercial potential of this STTR Phase I project is to address certain medical procedures, such as percutaneous nephrolithotomy (PCNL). Currently, one in 11 people develop kidney stones by the age of 70, with a lifetime recurrence rate of 60-80%. PCNL, which involves removal of kidney stones through a surgical channel into the kidney, is the preferred method for stones less th ...

    STTR Phase I 2020 National Science Foundation
  2. A novel role for Reelin therapeutics in inflammatory bowel disease

    SBC: REELIN THERAPEUTICS, INC.            Topic: 300

    Abstract Factors that contribute to the onset of inflammatory bowel disease (IBD) remain incompletely understood. Although specific genetic factors may increase risk, most IBD cannot be readily explained based on genetics. Dysbiosis in intestinal microbiomes also has been implicated. Once IBD is established, chronic inflammation is a central hallmark and also a major target for therapy. Both forms ...

    STTR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health
  3. Multiple Images Spatial Turbulence Imager (MISTI)


    Because of the maneuvering capabilities of adversaries’ new hypersonic weapons, defensive missiles must fly in very demanding flight regimes, and intercept maneuvers place stringent requirements on interceptor seeker systems. Successfully completing the hit-to-kill end game requires the seeker can either compensate for or perform despite the thermal and optical effects that cause the seeker to m ...

    STTR Phase II 2020 Department of DefenseMissile Defense Agency
  4. VICENT- Vibration Imaging for the Characterization of Extended, Non-cooperative Targets

    SBC: EXCITING TECHNOLOGY LLC            Topic: AF19AT006

    Exciting Technology, LLC (ET) and University of Dayton Research Institute (UDRI) along with their Transition partner Lockheed Martin Coherent Technologies (LMCT) plan to extend the Phase I phenomenology and wave optics simulations, and build a vibration imaging LiDAR for target phenomenology characterizations in controlled environments.  In addition, the team provides an optional path to accelera ...

    STTR Phase II 2020 Department of DefenseAir Force
  5. A Vaccine for Acute Flaccid Myelitis


    SUMMARYIn 2014 the United States experienced an outbreak of a previously unknown neurological disease with polio-like symptoms later known as acute flaccid myelitis (AFM). A biennial surge in cases of AFM in 2016 and 2018 has alarmed public health officials. Since then, rapidly accumulating clinical, immunological, and epidemiological evidence has pointed to EV-D68 as the major causative agent of ...

    STTR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health
  6. Learning from the Ebola success: Can a mAb also save lives after yellow fever infection?

    SBC: Mabloc, LLC            Topic: NIAID

    PROJECT SUMMARY/ABSTRACT The recent groundbreaking experiment using a single neutralizing monoclonal antibody (nmAb) to reduce the death rate in Ebola virus (EBOV)-infected individuals highlights the importance of this class of drug in the treatment of infectious disease. In August 2019, Dr. Anthony Fauci announced that administration of mAb114 had reduced the death rate from 70% to approximately ...

    STTR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health
  7. FH-Fc as a Pre-Exposure Prophylactic for Tickborne Disease

    SBC: Planet Biotechnology Incorporated            Topic: NIAID

    Lyme disease (LD) is the most prevalent vector-borne disease in the United States, with up to 300,000 cases a year. LD is caused by several species of the spirochete bacteria Borrelia burgdorferi sensu lato (the Lyme borreliae), which are transmitted by ticks from animal (bird, rodent) reservoirs to human hosts. While a short course of antibiotics is usually effective in eliminating the bacteria a ...

    STTR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health
  8. Vaccination against Zika virus infection using mosquito NeSt1 protein

    SBC: L2 DIAGNOSTICS LLC            Topic: NIAID

    Arthropod-borne viruses (arboviruses) present a substantial threat to human and animal health worldwide. They are transmitted by hematophagous arthropods, in which mosquitoes are one of the main transmitters. The mosquito specie, Aedes aegypti, is the primary mosquito vector of several widely spread arboviruses as zika, dengue or West Nile viruses. Mosquitoes transmit these pathogens by inoculatin ...

    STTR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health
  9. Additively Manufactured Internally Cooled Window Frame


    Mounting of infrared (IR) windows on hypersonic vehicles is a critical design issue because of the stresses caused by high temperatures combined with the coefficient of thermal expansion (CTE) mismatch between the window and frame materials. Many applications use elastomeric seals to limit window distortion and stress by allowing for joint flexibility. However, windows and frames operating in this ...

    STTR Phase II 2020 Department of DefenseMissile Defense Agency
  10. STTR Phase I: SynchronyGamma – A Music-Based Intervention for Alzheimer’s and MCI

    SBC: OSCILLOSCAPE, LLC            Topic: DH

    The broader/commercial impact of this Small Business Technology Transfer (STTR) Phase I project is to address age-related cognitive impairments. Neurodegenerative disorders are a rapidly growing public-health concern, with Alzheimer’s disease alone projected to affect 13.8 million Americans by 2050. Alzheimer’s disease patients undergo gradual cognitive decline and during this progression, pat ...

    STTR Phase I 2020 National Science Foundation
US Flag An Official Website of the United States Government